Theodore Levin

Oct 21, 2024 | acpjournals.org | Theodore Levin

: Annals of Internal MedicineGet full access to this articleView all available purchase options and get full access to this article. Supplemental MaterialReferences1. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153:307-323. [PMID: 28600072] doi: 10.1053/j.gastro.2017.05.0132.

Jul 19, 2024 | jamanetwork.com | Chyke A. Doubeni |Douglas A. Corley |Christopher Jensen |Theodore Levin

Key PointsQuestion  What is the colorectal cancer mortality benefit of screening with fecal immunochemical tests (FITs)? Findings  In this nested case control study of 10 711 individuals, completing a FIT to screen for colorectal cancer was associated with a reduction in risk of dying from colorectal cancer of approximately 33% overall, and there was a 42% lower risk for left colon and rectum cancers.